Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-10

Clinical Trial Update: Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on the safety and efficacy of a retinoid for severe chronic hand dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Retinoid (unspecified)

Snippet

Sponsor: Basilea Pharmaceutica | Conditions: Hand Dermatoses | Phase 3 | Status: COMPLETED